# Hooke Instruments

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hooke-instruments

- Industry: Medical Devices & Equipment
- Headquarters: Changchun, China
- Website: www.hooke-instruments.com
- Latest round: Series A (Jun 6, 2024)
- Investors on record: 3

## About

Established in 2017 and based in Changchun, China, Hooke Instruments operates as a biomedical instrument provider dedicated to providing optical scientific instruments. It has a sub-branch office in Hangzhou. The founder of the company, Bei Li graduated from the University of Bristol and is the research fellow at Chinese Academy of Sciences. The core scientific research team has more than 100 people, 50% of whom are masters or doctors. In June 2024, the company closed series A funding led by new investor Tsinghua Innovation Ventures.

The company mainly provides optical scientific instruments. Its products include single cell sorter, Raman spectrometer, intelligent cell counter, three-dimensional fluorescence imaging system, particle matter detector, nucleic acid amplification analyser, and cell sorting chip. The core product is PRECI SCS single cell sorter, which is a visualized single cell analysis and sorting platform and can be used in engineering cell screening, 3D bioprinting, and other fields. Hooke Instruments also provides microbial single cell full-process solutions. The products can be used in scientific research, medicine, pharmaceuticals, and other fields.

The company generates revenue by providing optical scientific instruments such as single cell sorter, spectrometer, and cell counter.

The company will use series A funding to accelerate the technology promotion of the company's single-cell phenotyping and sorting platform, and promote the commercialization and market development of industrial product pipelines such as pharmaceutical testing, microecological drug screening, and brewing monitoring.

## Funding rounds

- Series A, Jun 6, 2024 — Shunwei Capital, Tsinghua Innovation Ventures, Hangzhou Xiaochi Private Equity Fund Management

## Investors

- Shunwei Capital (https://capitalatlas.ai/funds/shunwei-capital) — Series A
- Tsinghua Innovation Ventures (https://capitalatlas.ai/funds/tsinghua-innovation-ventures) — Series A
- Hangzhou Xiaochi Private Equity Fund Management (https://capitalatlas.ai/funds/hangzhou-xiaochi-private-equity-fund-management) — Series A